Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
D002648:Child; D003961:Dianhydrogalactitol / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy; D013402:Sugar Alcohols / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced
D013402:Sugar Alcohols; D003961:Dianhydrogalactitol